Letteratura

Nuove conoscenze in senologia

Novità cliniche in letteratura senologica

I Forum di discussione

La NEWSLETTER di Senology

Ricerca documenti nel sito :

Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial

Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer.

Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies

Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates.

Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

Embryo development after heterotopic transplantation of cryopreserved ovarian tissue.

Phase III Randomized Trial of Calendula Officinalis Compared With Trolamine for the Prevention of Acute Dermatitis During Irradiation for Breast Cancer

The development of interval breast malignancies in patients with BRCA mutations

The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer

Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Effect of breast augmentation on the accuracy of mammography and cancer characteristics

Management of physiological gynaecomastia with tamoxifen

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.

Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial.

Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

Does timing of adjuvant chemotherapy for early breast cancer influence survival?

Lipid-lowering drug use and breast cancer in older women: a prospective study.

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer.

Application of immunofluorescence for intraoperative evaluation of sentinel lymph nodes in patients with breast carcinoma

Systematic review of fibroadenoma as a risk factor for breast cancer

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks

Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.

Limited-field radiation therapy in the management of early-stage breast cancer.

Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study.

Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.

Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer - Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women

Anastrozole Versus Tamoxifen as First-Line Therapy in Postmenopausal Patients With Hormone-Dependent Advanced Breast Cancer: A Prospective, Randomized, Phase III Study

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?

Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer

Elevated Mammaglobin (h-MAM) Expression in Breast Cancer Is Associated With Clinical and Biological Features Defining a Less Aggressive Tumour Phenotype

Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial

Tamoxifen and gallstone formation in postmenopausal breast cancer patients: retrospective cohort study

Treating Non-Hodgkin.s Lymphoma of the Breast?

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden

Does delay in starting treatment affect the outcomes of radiotherapy?

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer that Overexpresses HER2

Oral Contraceptives and the Risk of Breast Cancer

Heritability of Mammographic Density, a Risk Factor for Breast Cancer

Multicentric Mammary Carcinoma. Evidence of Monoclonal Proliferation

Cyclin E and Survival in Patients with Breast Cancer

Antipsychotic Dopamine Antagonists May Increase Breast Cancer Risk